Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill

Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market. Novo Nordisk, maker of Wegovy, and the U.S. Food and Drug Administration had threatened legal action against Hims & Hers, which announced over the weekend it would not sell the…